These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1837474)

  • 21. Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy.
    Beyer DC; McKeough T; Thomas T
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1299-305. PubMed ID: 15817331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.
    Zincke H; Lau W; Bergstralh E; Blute ML
    J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
    Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
    Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study of endocrine therapy in stage B and C prostate cancer].
    Uei T; Okazaki H; Nakamura T; Katou N; Suzuki K; Yamanaka H
    Hinyokika Kiyo; 2003 Nov; 49(11):639-43. PubMed ID: 14719450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reevaluation of MAB therapy and progress of endocrine therapy].
    Klotz L; Payne H; Gillatt D; Keane T; Morris C; Akaza H; Hirao ; Akakura K; Fukagai T
    Gan To Kagaku Ryoho; 2005 May; 32(5):705-28. PubMed ID: 15934164
    [No Abstract]   [Full Text] [Related]  

  • 26. Early results of a prospective study of hormone therapy for patients with locally advanced prostate carcinoma.
    Fowler JE; Bigler SA; Kolski JM; Yee DT
    Cancer; 1998 Mar; 82(6):1112-7. PubMed ID: 9506357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rational approach to androgen therapy for hypogonadal men with prostate cancer.
    Kaufman J
    Int J Impot Res; 2006; 18(1):26-31. PubMed ID: 16208401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Salvage radiotherapy in rising PSA after radical prostatectomy].
    Carrie C; Pommier P
    Cancer Radiother; 2007 Nov; 11(6-7):370-2. PubMed ID: 17869564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neoadjuvant therapy of prostate carcinoma].
    Ebert T
    Praxis (Bern 1994); 1997 Nov; 86(46):1815-8. PubMed ID: 9454282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy.
    D'Amico AV; Renshaw AA; Loffredo B; Chen MH
    Cancer; 2007 Oct; 110(8):1723-8. PubMed ID: 17828774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of locally advanced prostate cancer: a single institution study of 209 patients in Japan.
    Saito T; Kitamura Y; Komatsubara S; Matsumoto Y; Sugita T; Hara N
    Asian J Androl; 2006 Sep; 8(5):555-61. PubMed ID: 16847528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy.
    Yoshino T; Shiina H; Urakami S; Kikuno N; Yoneda T; Shigeno K; Igawa M
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6116-24. PubMed ID: 17062688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancer.
    Miyake H; Hara I; Eto H
    BJU Int; 2005 Oct; 96(6):791-5. PubMed ID: 16153202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-Fluorouracil versus folinic acid and 5-fluorouracil in advanced, hormone-resistant prostate cancer: a prospective randomized pilot trial.
    Breul J; Jakse G; Forster G; Lampel A; Rohani A; Hartung R
    Eur Urol; 1997; 32(3):280-3. PubMed ID: 9358213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of aminoglutethimide on steroid synthesis of the adrenal gland and its use in prostate cancer].
    Knönagel H; Hauri D
    Helv Chir Acta; 1989 Aug; 56(3):347-50. PubMed ID: 2807964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined surgery and immediate adjuvant hormonal treatment for stage D1 adenocarcinoma of the prostate: Mayo Clinic experience.
    Zincke H
    Semin Urol; 1990 Aug; 8(3):175-83. PubMed ID: 2399386
    [No Abstract]   [Full Text] [Related]  

  • 37. The benefits of early androgen blockade.
    Maroni PD; Crawford ED
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):317-29. PubMed ID: 18471789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.
    Qi H; Fillion C; Labrie Y; Grenier J; Fournier A; Berger L; El-Alfy M; Labrie C
    Cancer Res; 2002 Feb; 62(3):721-33. PubMed ID: 11830526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer.
    Amling CL; Lerner SE; Martin SK; Slezak JM; Blute ML; Zincke H
    J Urol; 1999 Mar; 161(3):857-62; discussion 862-3. PubMed ID: 10022701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of bicalutamide in adjuvant treatment of prostatic carcinoma after primary therapy with curative aim. The viewpoint of the surgeon].
    Rigatti P; Scattoni V
    Recenti Prog Med; 2002 Mar; 93(3):183-5. PubMed ID: 11942171
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.